RECOVERY & TISSUE REPAIR RESEARCH / COLOPHON
About This Research Desk
A citation-anchored casebook on four tissue-repair research peptides — filed by the evidence, not by the sales pitch.
What RegenLife Peptides is
RegenLife Peptides is a casebook of the published and preclinical research on four compounds studied for tissue repair and regeneration: BPC-157, GHK-Cu, the GLOW blend, and the Wolverine blend, with BPC-157 as the lead. It exists to make a frequently overstated literature legible — to set down, case by case, what each compound was actually studied for, in which species, and how far that evidence honestly reaches.
The organizing idea is regenerative and tissue-repair research, mapped for newcomers: two single compounds with genuinely different mechanisms (BPC-157's angiogenic profile, GHK-Cu's matrix-remodeling profile) and two research-community combinations (GLOW, Wolverine) built from those same compounds plus TB-500. Reading all four together clarifies which claims rest on controlled human trials, which rest on animal data, and which rest on nothing but a combination theory. Each compound has its own page; a comparison page lines up all four; and a single shared references list aggregates every source used across the site.
How the casebook is built
Three habits shape the casebook. First, every research claim is anchored to a numbered citation — peer-reviewed articles, systematic reviews, and pharmacokinetic studies, with DOIs and PubMed links, gathered on the references page. Second, each entry is filed at the strength it truly has: a two-person intravenous safety pilot is recorded as exactly that, never inflated into a safety guarantee; a rodent tendon-repair study stays a rodent study. Third, the four pages cross-reference one another, since the same peptides — BPC-157 and TB-500 above all — recur across pages, so the casebook links between them instead of repeating a claim in isolation.
What the casebook is not
RegenLife Peptides keeps a casebook; it runs no pharmacy, clinic, telehealth platform, or storefront. It sells, supplies, sources, and brokers no peptide, and holds no affiliate or referral tie to any research-chemical supplier. No clinicians sit behind it, no condition is diagnosed, nothing is prescribed, and no dose, schedule, or route is recommended for anyone.
None of the four compounds covered here is an FDA-approved medicine. Readers seeking clinical guidance should consult a licensed healthcare provider in their own jurisdiction. Notes on citation corrections or newly published research can go to the contact page; this desk reads that correspondence carefully but cannot answer requests for medical advice.